20
Sanofi Chimie Gentilly Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Cyanocobalamin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1998-056 - Rev 05
This Chemical Type CEP, issued on October 23, 2009, remains in force until February 03, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 547 associated with this CEP further emphasizes